MENU

CNTX Context Therapeutics Forecast, Technical & Fundamental Analysis

Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors... Show more

CNTX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
CNTX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

CNTX is expected to report earnings to fall 33.33% to -10 cents per share on November 11

Context Therapeutics CNTX Stock Earnings Reports
Q3'26
Est.
$-0.10
Q2'26
Missed
by $0.06
Q1'26
Beat
by $0.02
Q4'25
Missed
by $0.04
Q3'25
Missed
by $0.01
The last earnings report on August 05 showed earnings per share of -15 cents, missing the estimate of -9 cents. With 522.77K shares outstanding, the current market capitalization sits at 21.90M.
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BIOA4.990.15
+3.10%
BioAge Labs Inc.
GVA111.741.92
+1.75%
Granite Construction
WPM131.99-2.19
-1.63%
Wheaton Precious Metals Corp
AHG1.24-0.07
-5.34%
Akso Health Group ADS
SMXT4.55-0.36
-7.33%
Solarmax Technology Inc

CNTX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CNTX has been loosely correlated with ELTX. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if CNTX jumps, then ELTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNTX
1D Price
Change %
CNTX100%
-2.30%
ELTX - CNTX
41%
Loosely correlated
-0.64%
NMRA - CNTX
39%
Loosely correlated
-0.80%
PROK - CNTX
29%
Poorly correlated
+4.89%
TRAW - CNTX
28%
Poorly correlated
-1.29%
MREO - CNTX
27%
Poorly correlated
-0.30%
More
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Industry
N/A
Address
2001 Market Street
Phone
+1 267 225-7416
Employees
15
Web
https://www.contexttherapeutics.com
Context Therapeutics (CNTX) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com